Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Myeloid sarcoma without circulating leukemia mimicking gastrointestinal malignancy and lymphoma.

Ravulapati S, Siegel C, Dara A, Lionberger JM.

Hematol Rep. 2018 Jun 14;10(2):7040. doi: 10.4081/hr.2018.7040. eCollection 2018 May 14.

2.

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.

Stockstill K, Doyle TM, Yan X, Chen Z, Janes K, Little JW, Braden K, Lauro F, Giancotti LA, Harada CM, Yadav R, Xiao WH, Lionberger JM, Neumann WL, Bennett GJ, Weng HR, Spiegel S, Salvemini D.

J Exp Med. 2018 May 7;215(5):1301-1313. doi: 10.1084/jem.20170584. Epub 2018 Apr 27.

3.

Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk.

Schoen MW, Woelich SK, Braun JT, Reddy DV, Fesler MJ, Petruska PJ, Freter CE, Lionberger JM.

Leuk Res. 2018 May;68:72-78. doi: 10.1016/j.leukres.2018.03.005. Epub 2018 Mar 6.

PMID:
29574395
4.

Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia.

Woelich SK, Braun JT, Schoen MW, Ramlal R, Freter CE, Petruska PJ, Lionberger JM.

Anticancer Res. 2017 Feb;37(2):713-717.

PMID:
28179321
5.

Tumor lysis syndrome and metastatic melanoma.

Meeks MW, Hammami MB, Robbins KJ, Cheng KL, Lionberger JM.

Med Oncol. 2016 Dec;33(12):134. Epub 2016 Nov 2.

PMID:
27807723
6.

Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.

Lionberger JM, Pagel JM, Sandhu VK, Xie H, Shadman M, Mawad R, Boehm A, Dean C, Shannon-Dorcy K, Scott BL, Deeg HJ, Becker PS, Hendrie PC, Walter RB, Ostronoff F, Appelbaum FR, Estey EH.

Br J Haematol. 2014 Aug;166(3):375-81. doi: 10.1111/bjh.12905. Epub 2014 Apr 18.

7.

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia.

Walter RB, Laszlo GS, Lionberger JM, Pollard JA, Harrington KH, Gudgeon CJ, Othus M, Rafii S, Meshinchi S, Appelbaum FR, Bernstein ID.

Leukemia. 2014 Oct;28(10):1969-77. doi: 10.1038/leu.2014.107. Epub 2014 Mar 18.

8.

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Mawad R, Lionberger JM, Pagel JM.

Curr Hematol Malig Rep. 2013 Jun;8(2):132-40. doi: 10.1007/s11899-013-0153-6. Review.

9.

Gene expression changes in normal haematopoietic cells.

Lionberger JM, Stirewalt DL.

Best Pract Res Clin Haematol. 2009 Jun;22(2):249-69. doi: 10.1016/j.beha.2009.05.005. Review.

PMID:
19698932
10.

Advances in the management of patients with non-Hodgkin's lymphoma.

Lionberger JM, Armitage JO.

Expert Rev Anticancer Ther. 2001 Jun;1(1):43-52. Review.

PMID:
12113132
11.

Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.

Lionberger JM, Wilson MB, Smithgall TE.

J Biol Chem. 2000 Jun 16;275(24):18581-5.

12.
13.

The c-Fes family of protein-tyrosine kinases.

Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S, Dunham N.

Crit Rev Oncog. 1998;9(1):43-62. Review.

PMID:
9754447
14.

Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.

Read RD, Lionberger JM, Smithgall TE.

J Biol Chem. 1997 Jul 18;272(29):18498-503.

Supplemental Content

Loading ...
Support Center